|
|
|
|
| LEADER |
03984nam a2200553 4500 |
| 001 |
978-3-030-11272-1 |
| 003 |
DE-He213 |
| 005 |
20191022161351.0 |
| 007 |
cr nn 008mamaa |
| 008 |
190903s2019 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783030112721
|9 978-3-030-11272-1
|
| 024 |
7 |
|
|a 10.1007/978-3-030-11272-1
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RM1-950
|
| 072 |
|
7 |
|a MMG
|2 bicssc
|
| 072 |
|
7 |
|a MED071000
|2 bisacsh
|
| 072 |
|
7 |
|a MKG
|2 thema
|
| 082 |
0 |
4 |
|a 615
|2 23
|
| 245 |
1 |
0 |
|a Sleep-Wake Neurobiology and Pharmacology
|h [electronic resource] /
|c edited by Hans-Peter Landolt, Derk-Jan Dijk.
|
| 250 |
|
|
|a 1st ed. 2019.
|
| 264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2019.
|
| 300 |
|
|
|a X, 481 p. 56 illus., 42 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Handbook of Experimental Pharmacology,
|x 0171-2004 ;
|v 253
|
| 505 |
0 |
|
|a Part 1.Basic Principles -- 1. The Function(s) of Sleep -- 2. Neuroanatomical and Neurochemical Bases of Vigilance States -- 3. Omics Approaches in Sleep-Wake Regulation -- 4. The Role of Glia in Sleep Regulation and Function -- 5. Sleep- and Wake-Like States in Small 1 Networks In Vivo and In Vitro -- Part 2. Optogenetics and Pharmacogenetics -- 6. Optogenetic Dissection of Sleep-Wake States In Vitro and In Vivo -- 7. Pharmacosynthetic Deconstruction of Sleep-wake Circuits in the Brain -- 8. Clinical and Experimental Human Sleep-Wake Pharmacogenetics -- Part 3. Sleep-Wake Pathologies -- 9. Clinical Sleep-Wake Disorders I: Focus on Hypersomnias and Movement Disorders During Sleep -- 10. Clinical Sleep-Wake Disorders II: Focus on Insomnia and Circadian Rhythm Sleep Disorders -- Part 4. Current and New Targets, and Therapeutic Prospects -- 11. GABA Receptors and the Pharmacology of Sleep -- 12. Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood -- 13. Dopamine and Wakefulness: Pharmacology, Genetics, and Circuitry -- 14. Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood -- 15. Adenosine and Sleep -- Part 5. Outlook -- 16. Adenosine and Sleep -- 17. Functional Interactions Between Sleep and Circadian Rhythms in Learning and Learning Disabilities -- 18. Sleep Physiology, circadian rhythms, Waking Performance and the Development of Sleep-Wake Therapeutics.
|
| 520 |
|
|
|a The chapter 'Sleep Physiology, Circadian Rhythms, Waking Performance and the Development of Sleep-Wake Therapeutics' available open access under a CC BY 4.0 license at link.springer.com.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
|
0 |
|a Behavioral sciences.
|
| 650 |
|
0 |
|a Psychiatry.
|
| 650 |
|
0 |
|a Neurology .
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|0 http://scigraph.springernature.com/things/product-market-codes/B21007
|
| 650 |
2 |
4 |
|a Neurosciences.
|0 http://scigraph.springernature.com/things/product-market-codes/B18006
|
| 650 |
2 |
4 |
|a Behavioral Sciences.
|0 http://scigraph.springernature.com/things/product-market-codes/L13009
|
| 650 |
2 |
4 |
|a Psychiatry.
|0 http://scigraph.springernature.com/things/product-market-codes/H53003
|
| 650 |
2 |
4 |
|a Neurology.
|0 http://scigraph.springernature.com/things/product-market-codes/H36001
|
| 700 |
1 |
|
|a Landolt, Hans-Peter.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 700 |
1 |
|
|a Dijk, Derk-Jan.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783030112707
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783030112714
|
| 830 |
|
0 |
|a Handbook of Experimental Pharmacology,
|x 0171-2004 ;
|v 253
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-030-11272-1
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|